Clinical Trial Update: A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST [Phase 1]

View source ↗

Summary

Phase 1 trial update describing a drug-drug interaction study to assess how ripretinib affects the pharmacokinetics of a CYP2C8 probe substrate in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• QINLOCK (ripretinib)

Snippet

Sponsor: Deciphera Pharmaceuticals, LLC | Conditions: GIST - Gastrointestinal Stromal Tumor | Phase 1 | Status: COMPLETED